Myth vs Truth
1. Insurance companies don't want to cover stem cell therapies
Do you think your health insurance company has your best interest in mind when approving procedures? Or are they looking to save the most money?
Stem Cell therapy is not covered by insurance companies. Good news is that it is more affordable than ever before.
We never want to preclude anyone from receiving the benefits of stem cell therapy or learning more about this groundbreaking technology in health care. Therefore, while there will be out of pocket expenses associated with many of the regenerative techniques that we offer, we also accept all major insurances for those services that are covered. Once it is determined what interventions are required we will, in writing, discuss what your insurance covers and what the out of pocket expenses will be. You will be pleasantly surprised with the affordability of stem cell therapy.
2. My Orthopedic Doctor Recommended a Steroid Shot. Is there any harm in having it done?
In a recent study led by Timothy E. McAlindon of Tufts Medical Center in Boston, Massachusetts, researchers studied a total of 140 people with symptomatic knee arthritis. Half of the patients received steroid injections in their knees every 12 weeks for 24 months, while the other half only received placebo shots of saline on the same schedule.
Despite the extensive use of steroid shots as a treatment for those with arthritis, the research results actually showed that the shots caused a greater rate of cartilage loss in the knees over a two-year span than the placebo shots did. These results are very concerning. Why would patients want to treat their arthritic joints with a substance that will cause accelerated degeneration?
3. Is Stem Cell Therapy FDA approved?
The stem cells we use are processed from donated human tissue from full term, c-section deliveries in accordance with the FDA. CoreCyte™ is regulated as a human cell, tissue, or cellular or tissue-based product (HCT/P) under 21 CFR Part 1271 and Section 361 of the Public Health Service Act. Section 361 provides guidelines and regulations that tissue companies have to operate within to remain compliant. No 361 company has an FDA approved product, since they do not approve or disapprove products.
This question exposes a very common misconception. The FDA can only approve or deny drugs and devices, and stem cells are neither. So the FDA has no jurisdiction to either approve or deny stem cells. Our procedure falls under the category of physician’s practice of medicine governed by state licensure, wherein the physician and patient are free to consider their chosen course of treatment. Our procedure is compliant within the guidelines listed in the FDA Code of Federal Regulations 21 Part 1271. We meet FDA guidelines by providing a same-day procedure done entirely in clinic with only minimal manipulation of cells.
There are many misconceptions regarding stem cells. Ask us if you have questions. Listen to our patients. One of my favorite patients shared her results with us last week and we had to share with everyone!